Advantages of one step nucleic acid amplification (OSNA) whole node assay in sentinel lymph node (SLN) analysis in breast cancer

详细信息    查看全文

• 作者：Ana Santaballa ; Helena De La Cueva ; Carmen Salvador ; Ana M Garc铆a-Mart铆nez…
• 关键词：Sentinel lymph node biopsy ; Breast cancer ; Molecular analysis ; Micrometastases
• 刊名：SpringerPlus
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：2
• 期：1
• 全文大小：138KB
• 参考文献：Cserni G, Gregori D, Merletti F, et al.: Non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer: metaanalysis of 25 studies. Br JSurg 2004, 91:1245e52.CrossRef
  Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al.: Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23鈥?1): a phase 3 randomised controlled trial. Lancet Oncol 2013,14(4):297鈥?05.CrossRef
  Gant JS, Grant MD, Knox SM, et al.: Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann SurgOncol 2003, 10:126鈥?30.
  Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997, 15:2345鈥?350.
  Giuliano AE, Hunt K, Ballman KV, et al.: Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis. JAMA 2011,305(6):569鈥?75.CrossRef
  Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th眉rlimann B, Senn HJ: and the Panel members. Panel members. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol 2011, 22:1736鈥?747.CrossRef
  Guenther JM, Hansen NM, Di Fronzo LA, et al.: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003, 138:52鈥?6.CrossRef
  Guillen-Paredes MP, Carrasco-Gonzalez L, Chaves-Benito A, et al.: [One-step nucleic acid amplification (OSNA) assay for sentinel lymph node metastases as an alternative to conventional postoperative histology in breast cancer: A cost-benefit analysis.]. Cir Esp 2011,89(7):456e62.CrossRef
  Houvenaeghel G, Nos C, Giard S, et al.: A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J SurgOncol 2009, 35:690e5.
  Krag DN, Anderson SJ, Julian TB, et al.: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007, 8:881鈥?88.CrossRef
  Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al.: Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010,11(10):927鈥?33.CrossRef
  Langer I, Marti WR, Guller U, et al.: Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases. Ann Surg 2005, 241:152鈥?58.
  Li D, Xu X, Chen J, Chen J, Yang B, Yang W, et al.: Utility of one-step nucleic acid amplification (OSNA) assay in detecting breast cancer metastases of sentinel lymph nodes in a Chinese population. Breast Cancer Mar 21. [Epub ahead of print]
  Osako T, Iwase T, Kimura K, Yamashita K, Horii R, Yanagisawa A, et al.: Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology. Cancer 2011, 117:4365鈥?374.CrossRef
  Sagara Y, Ohi Y, Matsukata A, Yotsumoto D, Baba S, Tamada S, et al.: Clinical application of the one-step acid amplification method to detect sentinel node metastases in breast cancer. Breast Cancer 2011. doi:10.1007/s12282鈥?11鈥?324-z
  Sol谩 M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R, et al.: Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Ann Surg Oncol 2013,20(1):120鈥?27.CrossRef
  Tamaki Y, Akiyama F, Iwase T, Kaneko T, Tsuda H, Sato K, et al.: Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res 2009,15(8):2879鈥?884.CrossRef
  Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, et al.: One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007,13(16):4807鈥?816.CrossRef
  Weaver DL, Takamaru A, Krag DN, et al.: Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 2011, 364:412鈥?21.CrossRef
  
• 作者单位：Ana Santaballa (12)
  Helena De La Cueva (12)
  Carmen Salvador (12)
  Ana M Garc铆a-Mart铆nez (13)
  Mar铆a J Guar铆n (13)
  David Lorente (12)
  Laura Palomar (12)
  Ismael Aznar (14)
  Fernando Dob贸n (14)
  Pilar Bello (15)
  
  12. Medical Oncology Department, Hospital Universitari i Polit猫cnic La Fe, Valencia, Spain
  13. Anatomic Pathology Department, Hospital Universitari i Polit猫cnic La Fe, Valencia, Spain
  14. Surgery Department, Hospital Universitari i Polit猫cnic La Fe, Valencia, Spain
  15. Nuclear Medicine Department, Hospital Universitari i Polit猫cnic La Fe, Bulevar Sur s/n, 46026, Valencia, Spain
  
• 刊物类别：Science, general;
• 刊物主题：Science, general;
• 出版者：Springer International Publishing
• ISSN：2193-1801

文摘

Background The purpose of this study is to present our first results of sentinel node analysis (SLN) by one step nucleic acid amplification (OSNA) in routine clinical practice in our centre and compare them with the results of classic histopathological analysis in a historical cohort from our same institution.